HOME
Search
Site Map
ABOUT US
Staff
Licensure & Accreditations
Careers
DIAGNOSTIC SERVICES
Requisition Forms
Dermatopathology
Hematopathology
Heme/Onc
Molecular
All other pathology tests
HER2 Validation
Tests Offered
Sending Specimens
Billing
Technologies
IHC/IF
FISH
CISH
Flow
Molecular/PCR
Clinical Setting
Breast Marker Studies
Carcinoma of Unknown Primary
Large Cell Undifferentiated Malignant Neoplasm
Small, Blue, Round Cell Tumors of Childhood
Hematopathology
Mesothelioma v. Adenocarcinoma
Skin Immunofluorescence Studies
Spindle Cell Tumor/Sarcoma Subtyping
Identification of Organisms
Colorectal Tumor Prognostic & Predictive Markers
Other Frequently Requested Studies
Special Immunohistochemistry Studies
HER2 Validation
Sample Reports
Teaching Cases
Teaching Case 1
Teaching Case 2
Teaching Case 3
Teaching Case 4
Teaching Case 5
Teaching Case 6
Teaching Case 7
Teaching Case 8
Teaching Case 9
Teaching Case 10
Teaching Case 11
Teaching Case 12
Teaching Case 13
Teaching Case 14
Notice of Privacy Practices (HIPAA)
PhenoNet™
CONTRACT RESEARCH
Customized Studies
FDA Related Clinical Research
Screening of Polyclonal & Monoclonal Antibodies
Evaluation of Novel Antigens
Resources
Human Tissue, Tumor & Cell Lines
Antibody Bank
Methodologies
Analysis & Reporting
CONTACT US
Call or Email
Driving Directions
How Can We Help You?
Holidays
NEWS & EVENTS
Press Releases
Newsletter
Visit Us at Meetings
Pathology/IHC Conference
Educational Program
News for Patients
LOG IN
Press
Releases
Seattle-based PhenoPath Laboratories Retests Nearly 3,000 Breast Cancer Specimens from Quebec Breast Cancer Inquiry
, December 18, 2009
PhenoPath Laboratories Introduces KRAS Testing for Colorectal Tumors
, January 23, 2009
